Investment Summary

Ampersand Capital Partners Invests In Sterling Medical Devices

On June 23, 2022, growth capital firm Ampersand Capital Partners invested in medical products company Sterling Medical Devices

Investment Highlights
  • This is Ampersand Capital Partners’ 16th transaction in the Medical Products sector.
  • This is Ampersand Capital Partners’ 60th transaction in the United States.
  • This is Ampersand Capital Partners’ 7th transaction in New Jersey.

Investment Summary
Date 2022-06-23
Target Sterling Medical Devices
Sector Medical Products
Investor(s) Ampersand Capital Partners
Deal Type Growth Capital

Target

Sterling Medical Devices

Moonachie, New Jersey, United States
website
Sterling Medical Devices is a provider of custom electromechanical and software solutions for the medical device industry. Sterling Medical Devices was founded in 1998 and is based in Moonachie, New Jersey.

Search 192,510 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

website

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 70 of 79
Sector (Medical Products) 16 of 16
Type (Growth Capital) 23 of 26
State (New Jersey) 7 of 7
Country (United States) 60 of 65
Year (2022) 5 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-02 Vernal Biosciences

Colchester, Vermont, United States

Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation. Vernal Biosciences is based in Colchester, Vermont.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-25 Phosphorex

Hopkinton, Massachusetts, United States

Phosphorex is specializes in long-acting formulations, nanomedicine, and nucleic acid delivery solutions for leading pharmaceutical and biotechnology companies. Phosphorex is based in Hopkinton, Massachusetts.

Buy -
Mergr

Product

Company

Legal